FIN.10 - Design Financing Instruments and Terms

Type: Method

Status: Stable

FIN.10:0 - Use this when

The corporation needs funds and must compare an issue, loan, lease, committed line or other feasible arrangement. Model the terms that determine proceeds, future cash and rights. Use an already adequate committed arrangement directly when the task is only its permitted execution.

FIN.10:1 - Problem frame

Calculating an effective financing rate requires familiarity with compounding and discounting timed payments. Comparing adequate supplied proceeds and payment amounts can be sufficient without solving for that rate.

The object is a proposed financing arrangement and its financial consequences for the corporation. Instrument design includes amount, maturity, repayment, priority, collateral, currency, options and control terms. It does not itself secure investor acceptance or establish a disputed legal interpretation.

FIN.10:2 - Problem

The lowest headline rate can produce the highest effective cost, insufficient net proceeds or a maturity the corporation cannot meet. An indicative term sheet can be mistaken for committed funding.

FIN.10:3 - Forces

Balance cost, access, timing, flexibility, control and repayment risk. Retain contractual detail that can change the choice while keeping genuinely comparable alternatives visible.

FIN.10:4 - Solution

1. Recover the net amount and dates needed, currencies and expected repayment capacity. Include the effect of fees withheld at issue. Use FIN.2 where the funding requirement is unresolved.
2. Construct obtainable alternatives with their actual potential providers. Specify who supplies funds, who owes what, repayment and draw conditions, ranking, security, restrictions, conversion or exercise rights and required consents. Use FDM for an unresolved position or conditional event.
3. Project proceeds and every material payment under each alternative: interest or distribution terms, principal, issue and commitment fees, collateral or margin cash, tax consequences where supported, and contingent payments. Use the stated rate conventions, day counts, resets and settlement dates.
4. Compare the same funding requirement over the same horizon. Where meaningful, solve for the rate equating net proceeds with the discounted payments; retain any option or contingent risk that a single effective rate cannot represent.
5. Test refinancing and adverse states, collateral and covenant constraints, currency mismatch and control effects. Compare a long maturity with a rollover plan only if the latter includes its actual access uncertainty.
6. Obtain specific legal, tax, accounting or provider facts where they change the offer or its use. Distinguish proposed, offered, accepted, committed and currently drawable terms by what has actually occurred.
7. Return the preferred terms or conditional alternatives, total cash consequences and the unresolved condition. FIN.11 handles the larger financing mix and FIN.15 executes an authorized transaction.

Start with the financing service that is actually needed

Translate the proposed operating or investment action into net usable amounts, dates and currencies. Include the time until the first draw, any staged expenditure and the cash from which the financing will later be serviced. FIN.2 supplies that dated need; FIN.4 supplies the operating account behind it. A requirement for 100 available on Monday is not met by a commitment for 100 signed on Monday if settlement occurs on Friday or fees reduce proceeds to 98.

Clarify whether the comparison concerns new money, refinancing an existing obligation, a backstop or a continuing source of capital. Refinancing must include release of existing security, accrued interest, break costs and the overlap between old repayment and new settlement. A backstop must remain drawable in the state it is supposed to protect. Continuing funding requires a view of renewal and later investment, not just this period’s interest bill.

Form alternatives from sources the corporation could actually use. They can include retained cash, a loan or revolving facility, a debt security, new equity, a lease or a sale of an asset. These sources do not all preserve the same operating rights or ownership. A lease and purchase comparison needs FIN.6’s whole operating alternatives; a divestment needs FIN.9’s remaining-business effects. Retained cash is available only after its other uses and restrictions, and has an opportunity cost even though no external coupon is paid.

Distinguish an indicative possibility, a quoted offer subject to conditions, an executed commitment and settled funds. Compare conditional offers when that is the question, but keep their unmet conditions in the recommendation. Useful next work may be obtaining a term, release or commitment that changes the feasible set. It need not be a more precise ranking of offers that cannot fund the action.

Translate the instrument into changing claims and cash

Recover the actual borrower or issuer, financier, claim, security, ranking, guarantees, covenants and relevant options. FDM.3 derives events from terms and tracks the changing principal or other state; use that supplier rather than infer behavior from an instrument’s label. FDM.1–2 resolves which entity owes the money and whether another entity’s support is available. The financial comparison consumes those qualified events and adds cost, risk and fit to the need.

For debt, separate committed limit, amount drawn, outstanding principal and each payment due. A revolving facility permits repayment and redrawing only under its actual rules. A term loan may amortize principal, repay a bullet at maturity, or capitalize interest. Capitalized interest avoids an immediate payment but increases a later claim. Unused-line fees, upfront charges, minimum interest and mandatory repayments can make the cost depend on utilization and duration.

Construct each interest amount from its actual rate convention, reference rate, spread, reset dates, day count and outstanding balance. Include caps, floors or delayed resets if they change the comparison. A quoted annual nominal rate with monthly compounding differs from an effective annual rate. An amortizing loan’s later interest applies to remaining principal; treating the initial face amount as outstanding throughout overstates that interest. Conversely, applying the smaller closing balance to the whole period understates it.

Collateral and guarantees affect more than the quoted spread. A pledge may prevent another valuable use of the asset or reduce future borrowing capacity. A guarantee can move loss to another entity and may require payment or consent. Count its actual charge, exposure and effect on access; the collateral’s full market value is not automatically an immediate cash cost. FIN.12 establishes the resulting restrictions, and FIN.11 considers the whole financing position.

For equity, recover the interests issued, economic participation, voting or control rights, preference, conversion, redemption and any further funding obligations. A small stated percentage can carry rights that change its financial consequence. An investor’s required return is an opportunity cost and valuation input, not a promised coupon unless the actual instrument creates such a payment. Common equity with no mandatory redemption has different service risk from debt; a preference or redeemable instrument needs its own terms.

Put prices on a comparable basis without losing timing

Begin with net cash the corporation can use after issuance costs, withheld fees and any temporarily restricted proceeds. Then lay out the complete payments, recoverable deposits and other financial consequences. For a conventional loan with one initial net receipt and later payments, the effective financing rate is the rate that makes the present value of those payments equal to that receipt. Use their actual dates and a stated annualization convention. This rate reveals the effect of fees or amortization hidden by the coupon.

For irregular or state-dependent cash flows, a single rate can be incomplete or even have several mathematical solutions. Retain the cash schedule and compare supported present values, scenarios or contingent claims under FIN.5–8 as applicable. A promised yield can differ from the financier’s expected return when repayment is uncertain. Neither that yield nor the borrower’s average corporate WACC is automatically the right discount rate for every financing consequence.

Tax effects require the applicable entity, deductible amounts, use limits and payment dates. If a deduction cannot be used now, do not mechanically reduce today’s cost by the headline tax rate. FIN.5 supplies the qualified treatment of tax shields and risk. Keep their value either in the selected valuation or as an explicit separate effect, with no second credit for the same saving. A comparison before tax can be sufficient when tax consequences genuinely match or are immaterial to the question.

Compare identical financing service where possible. Two loans raising the same money now but repaying at different times provide different duration and liquidity support. The smaller nominal total payment can simply reflect earlier return of principal. If amounts differ, identify the use or cost of excess funds rather than choose the smallest rate without regard to need. If currency differs, incorporate actual conversion and any selected hedge; the lower foreign-currency coupon alone cannot rank the offers.

Match service obligations to the business under relevant states

Use the operating cash available after essential payments and investment to test service, preserving the required reserve. Compare dates and amounts, not merely the maturity label. A five-year facility with large annual amortization can demand more early cash than a shorter bullet loan. A bullet can fit early cash better while creating a concentrated refinancing or disposal need. Prove the proposed source of that repayment or retain it as a condition.

Consider which business exposures make financing harder to service. Floating interest can rise when operating cash is weak; fixed interest can cost more initially but reduce that exposure. Debt in a foreign currency may match genuine cash receipts in that currency, but a product sold there does not establish such a match if its price or settlement is actually in another currency. FIN.13 supplies the exposure analysis; FIN.14 handles a separate hedging choice where required. Asset and liability sensitivities can inform the design; approximate matching is not a guarantee against default.

An option to prepay, extend, convert or redraw has value only on its terms and in the states where it can be exercised. Identify who holds it. A lender’s call right can shorten the borrower’s dependable horizon, while a borrower’s extension subject to lender consent is not unconditional protection. A convertible’s lower coupon is paid for partly with an ownership claim; compare the joint instrument rather than treating the coupon reduction as free. Use a qualified valuation for material contingent terms or return the unresolved price as a range.

Select an obtainable arrangement and return its consequences

Compare the feasible offers on financial value, dated coverage, restrictions, exposure and effects on the chosen owners. Explain a trade-off when a cheaper expected arrangement is less dependable or sacrifices an important right. Do not hide it in an unexplained weighted score. The chosen objective and constraints come from FIN.1; the corporation-wide debt/equity policy comes from FIN.11.

Return the selected or conditional terms to FIN.2, FIN.4 and FIN.12. Recalculate cash, interest, tax, debt balances and covenant headroom. If the new financing creates another shortfall, change its amount, timing, instrument or the underlying action; do not retain both an old cash forecast and a new loan recommendation that no longer agree. The result can be a smaller feasible financing package, a negotiation position or an explicit absence of an obtainable offer.

A useful recommendation names the instrument and provider or provider class, net usable proceeds, draw and service dates, economic and ownership effects, and the conditions still needed before commitment or use. FIN.15 executes a sufficient authorized decision. FIN.10 does not turn its preferred terms into an executed contract.

FIN.10:5 - Archetypal Grounding

Two constructed one-year offers finance a net need of 100. A charges 8% interest on face value and withholds an issue fee of 2% of face value. B charges 9% and no fee. Assume no other cost, tax difference or contingent term and that A permits the necessary larger face amount. A must issue 100/0.98 = 102.04 and repay 102.04×1.08 = 110.20; its effective cost is 1.08/0.98−1 = 10.20%. B provides 100 and repays 109, so B is cheaper for this need despite its higher headline rate. If A is capped at face value 100, its net proceeds of 98 do not meet the need at all.

The same rate can provide different payment capacity

A separate corporation must pay 100 for an investment now and retain its existing cash reserve of 10. Two actually offered loans each deliver 100 net now, with no fees, tax differences or other restrictions. Both charge 10% annually on outstanding principal. Loan A repays 50 of principal at each year end; its payments are 60 in year 1 and 55 in year 2. Loan B pays interest 10 in year 1 and principal plus interest 110 in year 2. The investment and the rest of the business together provide cash of 28 and 115 at those year ends after every nonfinancing requirement. No additional source is available and no earlier shortfall occurs.

Loan A would leave 10 + 28 − 60 = −22 in year 1. Its nominal interest total of 15 does not make it usable. Loan B leaves 28 after year 1 and 33 after year 2, so it preserves the reserve at both dates. At a 10% comparison rate, each payment schedule has present value 100: 60/1.10 + 55/1.10² equals 10/1.10 + 110/1.10². The difference is the timing of principal use, not a lower effective rate.

If operating receipts move so that available cash becomes 60 in year 1 and 83 in year 2, preserving the total 143, Loan A leaves 10 and then 38. Both schedules now fit. Comparing their remaining cash requires the use and return of any interim surplus; comparing the final balances alone ignores that Loan B leaves more cash available after year 1. A decision to prefer one must therefore state that use or the relevant flexibility, not merely count interest.

The holder of a financing right changes the dependable horizon

In a separate constructed case, the company has cash 10, a required reserve of 5 and an investment payment of 100 now. Each offered loan supplies 100 net before that payment. The investment produces net cash 112 at month 12, with no interim receipt or other cash difference. Interest of 3 is payable at month 6; if the principal remains outstanding, another 3 is payable at month 12. Compare three stipulated versions, with no fees or other acceleration condition:

• The principal is due at month 6, but the borrower can extend it to month 12 by giving notice by the end of month 5. Timely notice is sufficient under the agreement; lender consent is not required.
• The same extension requires the lender’s affirmative consent by the end of month 5. The borrower’s request alone does not extend the loan.
• The stated maturity is month 12, but the lender may require repayment at month 6 by giving notice by the end of month 5.

After the initial draw and investment, cash remains 10. With the first version and a valid extension notice, the month-6 interest leaves 7. At month 12, cash becomes 7 + 112 − 100 − 3 = 16. The borrower’s exercisable right supplies the required horizon on the stated conditions.

For the second version without obtained consent, or the third after the lender’s call, month 6 requires principal and interest of 103. Preserving the reserve needs 103 + 5 − 10 = 98 of replacement net proceeds by that date. The positive month-12 investment return cannot pay this earlier maturity. Before committing, the company needs an arrangement that covers that branch, a different initial instrument or a changed investment plan. It cannot choose the lender’s future action as though that were its own extension option.

Suppose a separate replacement commitment is actually obtained by month 5 and supplies 98 net before the month-6 repayment, with conditions already satisfied and repayment of 103 at month 12. The month-6 account is 10 + 98 − 103 = 5; the final account is 5 + 112 − 103 = 14. This arrangement makes the early-repayment branch feasible on the given premises. If its proceeds instead settle after the old loan falls due, the arrangement does not repair the maturity gap.

These timelines establish dated availability and the resulting payments. Pricing the contingent rights is a further question requiring the qualified valuation grounds in FIN.8; the difference between final cash balances is not itself a price for an extension or call. FDM.3 supplies the actual notice, consent and claim events; FIN.2 tests their settlement order.

Equity finance prices a transferred interest

In another constructed offer, the existing equity is worth 200 immediately before financing. A new investor supplies 100 net, with no fees or special rights, and the cash is added to the business without any other value change. Equal ordinary interests imply post-money equity value 300. Issuing one third of that equity to the investor leaves the old owners with two thirds worth 200. If the investor instead requires 40% on these same valuation grounds, the old owners retain 60% of 300, or 180: a transfer of 20 relative to their starting interest.

This is a valuation comparison of the offer, not a claim that an investor must accept one third. A changed business value, funding urgency, preference or control right changes the comparison. If the cash funds an investment with its own gain, first include that attainable gain consistently; do not credit it wholly to old owners and also use it to justify the new investor’s percentage.

FIN.10:6 - Bias-Annotation

Provider quotations can omit conditions or vary in availability. A rate comparison can understate collateral, control, refinancing and concentrated-provider risks.

FIN.10:7 - Conformance Checklist

Does each alternative supply the required net cash at the required time? Are fees, repayment and contingent terms recoverable? Are comparable dates and conventions used? Is each commitment and consent claim supported, and is the residual funding need visible?

FIN.10:8 - Common Anti-Patterns and How to Avoid Them

Comparing coupons alone ignores issue economics; compare net proceeds and payments. Assuming a revolving facility will renew hides refinancing risk; show the expiry and available alternatives. Translating foreign debt at one spot rate can conceal future payment exposure; use FIN.13.

FIN.10:9 - Consequences

The comparison helps the corporation choose more useful terms or shows that a seemingly cheap offer cannot finance the requirement. It retains meaningful non-rate consequences for the receiving decision.

FIN.10:10 - Architectural Rationale

A cash-and-rights comparison connects instrument design to the corporation’s actual need. A single cost measure remains a useful projection, while conditions that change availability or control remain explicit.

FIN.10:11 - SoTA-Echoing

The AFP task domains locate professional financing responsibilities. Damodaran’s historical financing-details treatment explains how financing design relates to business cash and the transition from a desired mix. FIN.10 develops the obtainable offer, net proceeds, complete service and ownership consequences, using FDM.3 for contractual behavior and FIN.5 for qualified pricing. It retains asset–liability matching as an exposure question without adopting a claim that approximate matching eliminates default. The amortization and equity cases show why coupon or nominal total payment alone cannot rank offers. Current terms, tax and legal conditions require their own sources.

FIN.10:12 - Relations

FIN.2 supplies funding need; FIN.5 distinguishes required return from financing cost; FIN.11 compares the mix and FIN.12 its restrictions. FIN.13–14 assess financial exposure and protection. FIN.15 carries out the permitted financing action.

FIN.10:End